Synthorx to Present THOR-809 Data at the American College of Rheumatology (ACR) Annual Meeting
Synthorx, Inc. - Common Stock (THOR)
Last synthorx, inc. - common stock earnings: 11/5 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today announced that preclinical data highlighting THOR-809 will be presented at the American College of Rheumatology (ACR) Annual Meeting taking place in Atlanta from November 8-13, 2019. Marcos E. Milla, Ph.D., chief scientific officer of Synthorx, will present research supporting the development of THOR-809, the company’s lead Synthorin™ for the treatment of autoimmune disorders. THOR-809 is a site-specific, covalently-pegylated interleukin-2 (IL-2) variant that was discovered using Synthorx’ first-of-its-kind Expanded Genetic Alphabet platform. Preclinical models showed that the compound selectively expands regulatory T cells, without activating and expanding effector T or natural killer cells. Details of the poster presentation are as follows. For the full abstract, visit the ACR website. T
Show less
Read more
Impact Snapshot
Event Time:
THOR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
THOR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
THOR alerts
High impacting Synthorx, Inc. - Common Stock news events
Weekly update
A roundup of the hottest topics